Company Filing History:
Years Active: 2010-2011
Title: Bärbel Raupach: Innovator in Vaccine Development
Introduction
Bärbel Raupach is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, his work focuses on improving the efficacy of vaccines against serious diseases.
Latest Patents
Raupach's latest patents include a tuberculosis vaccine with improved efficacy. This invention relates to novel recombinant vaccines that provide protective immunity against tuberculosis. It also encompasses recombinant nucleic acid molecules, vectors containing these molecules, cells transformed with them, and polypeptides encoded by these nucleic acids. Another significant patent involves the identification of specific differentially expressed antigens. This invention pertains to compositions useful for immunization against pathogenic organisms and for diagnostic purposes. It includes a composition comprising at least one protein that is differentially expressed in a virulent strain compared to an avirulent strain. Furthermore, it relates to pharmaceutical and diagnostic compositions that utilize the compounds developed in this research.
Career Highlights
Throughout his career, Bärbel Raupach has worked with prestigious organizations, including the Max Planck Society for the Advancement of Science. His research has contributed to advancements in vaccine technology and immunology.
Collaborations
Raupach has collaborated with esteemed colleagues such as Stefan H. E. Kaufmann and Leander Grode. These partnerships have further enhanced the impact of his research in the scientific community.
Conclusion
Bärbel Raupach's innovative work in vaccine development has the potential to significantly improve public health outcomes. His contributions to the field of immunology are noteworthy and continue to inspire future research.